Skip to Main Content
Scientist speaking to his female colleague holding clipboard

Speakers

Featured SPeakers

Plenary Speakers

  • Morrey Atkinson, PhD, VP of Biologics Development, BMS
  • Lucinda Buhse, PhD, Director of OTR, OPQ/OCDER/FDA

Session Speakers

  • Julie Murrell, Head, Cell Therapy Bioprocessing, MilliporeSigma
  • Caroline Dugopolski, VP, Technical Operations, Histogenics
  • Karen Nichols, Chief Regulatory Officer, ISCT
  • Yu-Kyeong Hwang, R&D Head, Green Cross LabCell
  • Kelvin Lee, Professor, NIIMBL Director, University of Delaware
  • Sean Bermingham, VP, Life Sciences and Principal Consultant, PSE Enterprise Inc.
  • Mark Bruso, Manager, Labor Market Research, Massbio
  • Tom Bollenback, Chief Technology Officer, Advanced Regenerative Manufacturing Institute
  • Cyrus Agarabi, Regulatory Research Officer, OBP / FDA/ CDER/DBR II
  • Armin Opitz, Sr. Process Engineer, Sanofi
  • Palani Palaniappan, Head, Biologics & New Modalities Development, Pharmaceutical Sciences, Takeda
  • Joseph Shiloach, Director, Biotechnology Core Laboratory, NIDDK / NIH
  • Roger Hart, Scientific Director, Drug Substance Process Development, Amgen
  • Dr. Mark Klempner, Executive Vice-Chancellor, MassBiologics & Professor, UMass Medical School
  • Ying Jing, Sr. Director of Cell-line and Cell Culture, Dimensiontx
  • Paul Fleming, Sr. Project Manager, Lonza Biologics
  • Michael McCaman, VP, Process Sciences, Intellia Therapeutics
  • David Dismuke, Director, Vector Production, Voyager Therapeutics, Inc